KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Insys Therapeutics Stock and on which exchange is it traded?
The symbol for Insys Therapeutics is INSY and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Insys Therapeutics Stock?
Insys Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Insys Therapeutics Stock?
Insys Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Insys Therapeutics Stock.

What's the current price of Insys Therapeutics Stock?
As of the end of day on the Sep 17, 2019, the price of an Insys Therapeutics (INSY) share was $0.255.

What is the 52-week high and low for Insys Therapeutics Stock?
The 52-week high for Insys Therapeutics Stock is $10.44 and the 52-week low is $0.142.
Click to get the best stock tips daily for free!

About Insys Therapeutics

Insys Therapeutics Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets Subsys, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients in the United States. Its lead product candidate is Syndros, an orally administered liquid formulation of dronabinol. The company is also developing Cannabidiol Oral Solution, a synthetic cannabidiol for childhood ... INSY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT